David C. Myles
Chief Scientific OfficerDr. David C. Myles, Ph.D., is Chief Scientific Officer of Olema Oncology, Inc. (formerly known as Olema Pharmaceuticals, Inc.) from March 2026. He was Chief Discovery and Non-Clinical Development Officer at Olema Oncology, Inc. (formerly known as Olema Pharmaceuticals, Inc.) since September 2022. He had been the Chief Development Officer of Olema Oncology, Inc. (formerly known as Olema Pharmaceuticals, Inc.) since June 2020 until 2022 and served as its Executive Vice President, Drug Discovery and Development in April 2008. He joined Olema in April 2008. Dr. Myles Co-Founded Epiphany Biosciences, Inc. in 2001 and served its Chief Operating Officer from 2006 to 2008. Dr. Myles served as Executive Director, Chemistry of Kosan Biosciences from January 2001 to November 2006. Prior to joining Kosan in May 2001, Dr. Myles was Associate Director, Organic and Medicinal Chemistry at Chiron Corporation from 1998 to 2001. From 1991 to 1998, Dr. Myles held a faculty position in the Department of Chemistry and Biochemistry at the University of California, Los Angeles. He is a recipient of the National Science Foundation Young Investigator award and the Alfred P. Sloan Foundation fellowship. He serves as the Finance Chair on Board of Directors of Point Blue. Dr. Myles has over 100 publications, issued US patents and published US patent applications and is an editor of annual Reports in Medicinal Chemistry. Dr. Myles received the inaugural NIH/Lawton Chiles Biotechnology Fellowship in the Department of Chemistry at Harvard University where he studied organic synthesis using biocatalysts. He received a B.A. in chemistry from Occidental College and his Ph.D. in chemistry from Yale University in 1989.
Positions
- Company NameOlema Oncology, Inc.Stock CodeOLMAPositionChief Scientific OfficerColleagues
- SPSean P. BohenPresident, CEO & Director
- ITIan T. ClarkIndependent Chairperson of the Board
- SMShawnte M. MitchellChief Legal Officer & Corporate Secretary
- JOJason O’ByrneCFO, Principal Financial Officer & Accounting Officer
- COCourtney O'KonekVice President of Corporate Communications
- FPFrank P. McCormickChairman of Scientific Advisory Board
- CMCynthia Marie ButittaIndependent Director
- SGScott GarlandIndependent Director
